Abstract 81P
Background
Single-cell technologies have revealed novel insights about the complexity of the tumor immune microenvironment. Most clinical strategies rely on histopathological stratification of tumor subtypes, yet the spatial context of cellular interactions within these stratified subgroups remains poorly understood. We previously applied imaging mass cytometry, a novel technology, to describe the tumor and immunological landscape of lung adenocarcinoma (LUAD) patient tumors across five histological subtypes of lung adenocarcinoma. We resolved over 1 million cells, enabling an understanding of the cellular spatial relationships associated with distinct clinical correlates, such as survival. Here, we compare the immune landscape of LUAD with lung squamous cell carcinoma (LUSC), a different subtype of lung cancer.
Methods
Imaging mass cytometry (IMC) is a novel technology which allows for the use of up to 50 antibodies labelled with metal isotopes to characterize the tumour and the tumour immune microenvironment. Our research group has optimized a panel of IMC markers delineating immune, tumour and structural cell types. Using IMC we have assessed the frequency of 16 different cell types, the interactions across these cells and their organization into cellular communities. We have compared these outputs across LUAD and LUSC patients.
Results
We show that LUAD and LUSC exhibit distinct immune profiles. Lung squamous cell carcinoma is characterized by a higher prevalence of neutrophils and a lower prevalence of macrophages compared to LUAD. In addition, our spatial analysis of immune lineages demonstrates contrasting cellular interactions across LUAD and LUSC as well as unique arrangements of immune cells into cellular neighborhoods. This highlights the spatial heterogeneity that exists across lung cancer subtypes beyond the prevalence of immune cell types alone.
Conclusions
Our results describe the importance of spatial interactions by demonstrating how distinct spatial profiles can exist across subtypes of lung cancer. Overall, we find unique immune profiles across LUAD and LUSC as it relates to immune frequencies, pairwise cellular interactions and communities of cells.
Editorial acknowledgement
Clinical trial identification
Legal entity responsible for the study
The authors.
Funding
Rosalind and Morris Goodman Chair in Lung Cancer Research.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
72P - Role of pyruvate carboxykinase 2 upregulation in group 3 medulloblastoma: Implications for metabolic reprogramming and therapeutic strategies
Presenter: MEDHA GAYATHRI PAI
Session: Cocktail & Poster Display session
Resources:
Abstract
73P - Effect of combination therapy with atezolizumab plus metformin on peripheral immune cells from NSCLC patients
Presenter: Luisa Amato
Session: Cocktail & Poster Display session
Resources:
Abstract
74P - Obesity regulates tumor progression and sensitivity to checkpoint blockade through the diet-microbiota-immunity axis
Presenter: Lysanne Desharnais
Session: Cocktail & Poster Display session
Resources:
Abstract
75P - Possible significance of the proline at position 325 in the recognition of the MX35 epitope of the NaPi2b transporter by monoclonal antibodies
Presenter: Leisan Bulatova
Session: Cocktail & Poster Display session
Resources:
Abstract
76P - Circadian control of neutrophil extracellular trap formation temporally regulates metastatic lung cancer progression
Presenter: Simon Milette
Session: Cocktail & Poster Display session
Resources:
Abstract
78P - Daily rhythmic expression of pro-tumoral programs in NSCLC shape cancer immunity and therapy response
Presenter: Alba de Juan
Session: Cocktail & Poster Display session
Resources:
Abstract
79P - Tumor cell-released autophagosomes (TRAPs) remodel the breast tumor microenvironment by inducing the formation of inflammatory cancer-associated fibroblasts (CAFs)
Presenter: Chengdong Wu
Session: Cocktail & Poster Display session
Resources:
Abstract
80P - Tumor microenvironment (TME) defines prognosis of EGFR-mutant non-small cell lung cancer (NSCLC)
Presenter: Lodovica Zullo
Session: Cocktail & Poster Display session
Resources:
Abstract
82P - Tumor cell-released autophagosomes (TRAPs) promote breast cancer lung metastasis by modulating neutrophil extracellular traps formation
Presenter: XIAOHE ZHOU
Session: Cocktail & Poster Display session
Resources:
Abstract
83P - Evaluation of serum macrophage inhibitory cytokine 1 as a diagnostic biomarker for pancreatic cancer: A systematic review and diagnostic accuracy meta-analysis
Presenter: Muhammed Elfaituri
Session: Cocktail & Poster Display session
Resources:
Abstract